Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.76 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | RAB9A | P51151 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | MGLL | Q99685 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.55 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.55 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27716579 | 0.98 | BCL9 (0.73) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL11096336 | 0.94 | BCL9 (0.68) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL10727099 | 0.91 | MAPT (0.70) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL2738370 | 0.89 | BCL9 (0.66) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL10727729 | 0.87 | MAPT (0.65) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL10722598 | 0.87 | MAPT (0.65) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL133257 | 0.86 | BCL9 (1.00) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL20467771 | 0.86 | HTR2A (0.71) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL9967879 | 0.85 | BCL9 (0.70) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL957930 | 0.85 | BCL9 (0.81) | BCL9CTNNB1KMT2ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | claimed |
| US-20220062906-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2022-03-03 | — | — | US | claimed |
| CN-113784801-A | Organic phosphorus detection device | 普兰特瓦可思公司 | 2021-12-10 | — | — | CN | claimed |
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | claimed |
| US-20200360317-A1 | CARBOXYLIC ACIDS FOR TREATING/PREVENTING A SKIN DISEASE | PROPONENT BIOTECH GMBH (CH) | 2020-11-19 | — | — | US | claimed |
| WO-2020227413-A1 | DEVICE FOR DETECTING ORGANOPHOSPHATES | PLANTVAX, INC. (US) | 2020-11-12 | — | — | WO | claimed |
| EP-3630798-A1 | ENGINEERED POLYPEPTIDES AND THEIR APPLICATIONS IN SYNTHESIS OF BETA-HYDROXY-ALPHA-AMINO ACIDS | Enzymaster (Ningbo) Bio-Engineering Co., Ltd. (CN) | 2020-04-08 | — | — | EP | claimed |
| US-20190160030-A1 | CARBOXYLIC ACIDS FOR EARLY CHILDHOOD APPLICATION | PROPONENT BIOTECH GMBH (CH) | 2019-05-30 | — | — | US | claimed |
| WO-2018219107-A1 | ENGINEERED POLYPEPTIDES AND THEIR APPLICATIONS IN SYNTHESIS OF BETA-HYDROXY-ALPHA-AMINO ACIDS | ENZYMASTER (NINGBO) BIO-ENGINEERING CO., LTD. (CN) | 2018-12-06 | — | — | WO | claimed |
| US-20100267044-A1 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | FRANCISKOVICH PHILLIP P | 2010-10-21 | — | — | US | claimed |
| EP-2084294-A2 | STERILIZATION INDICATOR | American Sterilizer Company (US) | 2009-08-05 | — | — | EP | claimed |
| EP-2084293-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | American Sterilizer Company (US) | 2009-08-05 | — | — | EP | claimed |
| US-20090117603-A1 | STERILIZATION INDICATOR | FRANCISKOVICH PHILLIP P | 2009-05-07 | — | — | US | claimed |
| WO-2008082728-A2 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
| WO-2008079469-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-20080070231-A1 | Reporter genes taken up by microorganism, and repressor gene inhibits expression | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20080070272-A1 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| CN-1451751-A | Thermophilic esterase/phosphatidase gene, engrg. bacteria, enzyme and use thereof | UNIV JILIN (CN) | 2003-10-29 | — | — | CN | claimed |
| EP-0239354-A2 | 2,2-Dinitrophenylethane derivatives and their application as protecting compounds | Wendstone Chemicals P.L.C. (GB) | 1987-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | BCHE, LIPE, ACHE | BCL9 2500/4885CTNNB1 3981/4885KMT2A 1231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.